Over 65,000 ineligible providers have been culled from the Medicaid program due to a component of the Affordable Care Act (ACA) that requires periodic recertification of eligibility.
Over 65,000 ineligible providers have been culled from the Medicaid program due to a component of the Affordable Care Act that requires periodic recertification of eligibility, according to Modern Healthcare.
The measure, which was meant to prevent fraud and inefficiency, called for providers that enrolled in Medicaid before March 2011 to send “revalidation notices” to CMS to prove their eligibility for reimbursement. Failure to submit a notice by September 25, 2016, meant the provider could be scrubbed from the state Medicaid rolls.
Some common reasons for ineligibility were that they were no longer located in that state, they only enrolled a single patient, or they quit the program. Many of those who left voluntarily said that low reimbursement rates contributed to that decision, the Modern Healthcare article reported.
Another roadblock was that some of the letters notifying providers of the recertification requirement could not be delivered, as their addresses in the Medicaid system were outdated or incorrect. A survey in October found that databases for Medicare Advantage, another CMS program, were rife with inaccuracies, with almost 46% of listings containing errors.
The move comes as CMS has been scrutinized for inefficiencies and waste. In a hearing last month, Vicki Robinson of the Office of the Inspector General in HHS testified that her office had found a number of vulnerabilities in eligibility verification protocols and federal payment controls within CMS. She could not answer lawmakers’ questions about whether the resulting fraud and waste had caused consumers’ premiums to rise.
Some advocates worry that these efforts to control spending and prevent abuse disregard the need to ensure beneficiaries have adequate provider options. According to the Modern Healthcare article, a spokesman for the Texas Medical Association voiced concerns that the move could “jeopardize patient access to care given concerns about network adequacy” in a state that had almost 10% of its Medicaid providers wiped from the program by this rule.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More